Epicentrx Awarded Funding From Fightmnd To Evaluate Therapeutic Potential Of Rrx-001 In Motor Neuron Disease (Aka Als)
Round Type
Funding Round
La JollaBiotechnologyPharmaceuticalBiopharmaDescription
EpicentRx Inc. ("EpicentRx"), a late-stage biopharmaceutical company with platforms that treat and target multiple immune-mediated inflammatory disorders, and FightMND, Australia's largest independent funder of research in motor neuron disease (MND), are pleased to announce that EpicentRx has been awarded funding from FightMND to evaluate the potential neuroprotective benefits of the company's lead small molecule, RRx-001. RRx-001, a direct NLRP3 inflammasome inhibitor, will be evaluated as a novel disease modifying therapy for MND.
Quick answer
EpicentRx raised an undisclosed amount in a Funding Round round, dated November 29, 2022. EpicentRx is based in La Jolla, California, United States.
- How much did EpicentRx raise?
- EpicentRx raised an undisclosed amount in a Funding Round round on November 29, 2022.
- What does EpicentRx do?
- EpicentRx is a leading-edge biopharmaceutical company with a complementary pipeline of small molecules, novel drug delivery devices, and cancer selective virus platforms that target inflammatory diseases of significant..
- Where is EpicentRx based and how big is it?
- EpicentRx is based in La Jolla, California, United States.
Source: Fundz verified event record.
Who else raised in Pharmaceutical and Biopharma around the same time
Companies in the same sectors as EpicentRx that raised within 45 days of this round, from Fundz verified event records.
- HighTide Therapeutics raised $107M (Series C) on January 5, 2023.
- Sihuan Pharmaceutical Holdings Group raised an undisclosed amount (Funding Round) on January 4, 2023.
- Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
- Entero Therapeutics raised $2.5M (Seed) on November 22, 2022.
- Parabilis Medicines raised $178M (Series D) on November 21, 2022.
- Citius Pharmaceuticals, Inc. raised $3.6M (Seed) on November 21, 2022.
Who to call at EpicentRx, and when
A new round usually means EpicentRx is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day EpicentRx raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at EpicentRx, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at EpicentRx. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment EpicentRx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
EpicentRx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.